Rolls-Royce wins major engine contract with US Armed Forces
Power systems group Rolls-Royce is to provide service support for a number of engines used by the US Armed Services.
Power systems group Rolls-Royce is to provide service support for a number of engines used by the US Armed Services.
The contracts, worth more than $275m collectively, will see Rolls-Royce provide 'Mission Care' service support for AE 1007C, AE 2100 and T56 engines which power a variety of aircraft, including the V-22, C-130, P-3 and C-2 in operation with the US Air Force, Navy and Marines.
"Rolls-Royce is focused on meeting all of our military customers' needs and we deliver services and support packages tailored to meet their specific requirements," said President of the company's North American Customer Business, Patricia O'Connell.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"These contracts reflect the confidence our US military customers have in our expertise. Rolls-Royce continues to win new contracts by demonstrating the value we can add, and by working hard to ensure our customers can deliver their missions and work within their budget," she said.
The work is to be delivered in 2012 and 2013.
BC
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published